Is Hims Hers Stock a Good Investment?
Hims Hers Investment Advice | HIMS |
- Examine Hims Hers' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Hims Hers' leadership team and their track record. Good management can help Hims Hers navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Hims Hers' business and its evolving consumer preferences.
- Compare Hims Hers' performance and market position to its competitors. Analyze how Hims Hers is positioned in terms of product offerings, innovation, and market share.
- Check if Hims Hers pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Hims Hers' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Hims Hers Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Hims Hers Health is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Good | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Hims Hers Stock
Researching Hims Hers' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 80.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years.
To determine if Hims Hers is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Hims Hers' research are outlined below:
| Hims Hers Health is way too risky over 90 days horizon | |
| Hims Hers Health appears to be risky and price may revert if volatility continues | |
| Hims Hers Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 872 M. Net Loss for the year was (23.55 M) with profit before overhead, payroll, taxes, and interest of 1.01 B. | |
| Over 80.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Why Hims Hers Health Shares Are Getting Obliterated Today |
Hims Hers Quarterly Accounts Payable |
|
Hims Hers uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Hims Hers Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Hims Hers' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Hims Hers' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Hims Hers' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-06 | 2023-09-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2022-11-07 | 2022-09-30 | -0.1 | -0.09 | 0.01 | 10 | ||
2022-05-09 | 2022-03-31 | -0.07 | -0.08 | -0.01 | 14 | ||
2024-08-05 | 2024-06-30 | 0.04 | 0.06 | 0.02 | 50 | ||
2023-08-07 | 2023-06-30 | -0.05 | -0.03 | 0.02 | 40 | ||
2023-05-08 | 2023-03-31 | -0.07 | -0.05 | 0.02 | 28 | ||
2023-02-27 | 2022-12-31 | -0.07 | -0.05 | 0.02 | 28 | ||
2021-11-10 | 2021-09-30 | -0.06 | -0.08 | -0.02 | 33 |
Hims Hers Target Price Consensus
Hims target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Hims Hers' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 13 | Buy |
Most Hims analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Hims stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Hims Hers Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationHims Hers Target Price Projection
Hims Hers' current and average target prices are 39.86 and 26.20, respectively. The current price of Hims Hers is the price at which Hims Hers Health is currently trading. On the other hand, Hims Hers' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Hims Hers Market Quote on 25th of February 2025
Target Price
Analyst Consensus On Hims Hers Target Price
Hims Hers Analyst Ratings
Hims Hers' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Hims Hers stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Hims Hers' financials, market performance, and future outlook by experienced professionals. Hims Hers' historical ratings below, therefore, can serve as a valuable tool for investors.Know Hims Hers' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Hims Hers is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hims Hers Health backward and forwards among themselves. Hims Hers' institutional investor refers to the entity that pools money to purchase Hims Hers' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-12-31 | 2.6 M | Arrowstreet Capital Limited Partnership | 2024-09-30 | 2.2 M | Northern Trust Corp | 2024-12-31 | 2 M | Two Sigma Investments Llc | 2024-12-31 | 2 M | Citadel Advisors Llc | 2024-09-30 | 1.9 M | Qube Research & Technologies | 2024-12-31 | 1.9 M | Charles Schwab Investment Management Inc Usd | 2024-12-31 | 1.8 M | Charles Schwab Investment Management Inc Usd | 2024-12-31 | 1.8 M | Blackrock Inc | 2024-12-31 | 30.1 M | Vanguard Group Inc | 2024-12-31 | 20.3 M | Farallon Capital Management, L.l.c. | 2024-12-31 | 8.4 M |
Hims Hers' market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 11.21 B.Market Cap |
|
Hims Hers' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.23 | 0.24 | |
| Return On Capital Employed | 0.13 | 0.13 | |
| Return On Assets | 0.18 | 0.19 | |
| Return On Equity | 0.26 | 0.28 |
Determining Hims Hers' profitability involves analyzing its financial statements and using various financial metrics to determine if Hims Hers is a good buy. For example, gross profit margin measures Hims Hers' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Hims Hers' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Hims Hers' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hims Hers Health. Check Hims Hers' Beneish M Score to see the likelihood of Hims Hers' management manipulating its earnings.
Evaluate Hims Hers' management efficiency
Hims Hers Health has return on total asset (ROA) of 0.0566 % which means that it generated a profit of $0.0566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2635 %, meaning that it created $0.2635 on every $100 dollars invested by stockholders. Hims Hers' management efficiency ratios could be used to measure how well Hims Hers manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.24 in 2025. Return On Capital Employed is likely to gain to 0.13 in 2025. At this time, Hims Hers' Net Tangible Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 19.2 M in 2025, whereas Total Current Assets are likely to drop slightly above 180 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.21 | 2.32 | |
| Tangible Book Value Per Share | 1.48 | 1.56 | |
| Enterprise Value Over EBITDA | 80.97 | 85.02 | |
| Price Book Value Ratio | 10.95 | 7.51 | |
| Enterprise Value Multiple | 80.97 | 85.02 | |
| Price Fair Value | 10.95 | 7.51 | |
| Enterprise Value | 5 B | 5.3 B |
Hims Hers Health has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 1.35 |
Basic technical analysis of Hims Stock
As of the 25th of February, Hims Hers retains the Downside Deviation of 6.59, market risk adjusted performance of 659.06, and Risk Adjusted Performance of 0.1629. Hims Hers technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Hims Hers Health coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Hims Hers is priced fairly, providing market reflects its last-minute price of 39.86 per share. Given that Hims Hers Health has jensen alpha of 1.58, we strongly advise you to confirm Hims Hers Health's regular market performance to make sure the company can sustain itself at a future point.Hims Hers' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hims Hers insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hims Hers' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hims Hers insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hims Hers' Outstanding Corporate Bonds
Hims Hers issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hims Hers Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hims bonds can be classified according to their maturity, which is the date when Hims Hers Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Hims Hers' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Hims Hers' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1629 | |||
| Market Risk Adjusted Performance | 659.06 | |||
| Mean Deviation | 5.33 | |||
| Semi Deviation | 5.77 | |||
| Downside Deviation | 6.59 | |||
| Coefficient Of Variation | 477.24 | |||
| Standard Deviation | 7.6 | |||
| Variance | 57.7 | |||
| Information Ratio | 0.2089 | |||
| Jensen Alpha | 1.58 | |||
| Total Risk Alpha | 1.63 | |||
| Sortino Ratio | 0.2408 | |||
| Treynor Ratio | 659.05 | |||
| Maximum Drawdown | 32.02 | |||
| Value At Risk | (7.39) | |||
| Potential Upside | 12.1 | |||
| Downside Variance | 43.4 | |||
| Semi Variance | 33.24 | |||
| Expected Short fall | (6.37) | |||
| Skewness | 0.3457 | |||
| Kurtosis | 4.07 |
| Risk Adjusted Performance | 0.1629 | |||
| Market Risk Adjusted Performance | 659.06 | |||
| Mean Deviation | 5.33 | |||
| Semi Deviation | 5.77 | |||
| Downside Deviation | 6.59 | |||
| Coefficient Of Variation | 477.24 | |||
| Standard Deviation | 7.6 | |||
| Variance | 57.7 | |||
| Information Ratio | 0.2089 | |||
| Jensen Alpha | 1.58 | |||
| Total Risk Alpha | 1.63 | |||
| Sortino Ratio | 0.2408 | |||
| Treynor Ratio | 659.05 | |||
| Maximum Drawdown | 32.02 | |||
| Value At Risk | (7.39) | |||
| Potential Upside | 12.1 | |||
| Downside Variance | 43.4 | |||
| Semi Variance | 33.24 | |||
| Expected Short fall | (6.37) | |||
| Skewness | 0.3457 | |||
| Kurtosis | 4.07 |
Consider Hims Hers' intraday indicators
Hims Hers intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hims Hers stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Hims Hers Corporate Filings
8K | 24th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 20th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 23rd of January 2025 Other Reports | ViewVerify |
Hims Stock media impact
Far too much social signal, news, headlines, and media speculation about Hims Hers that are available to investors today. That information is available publicly through Hims media outlets and privately through word of mouth or via Hims internal channels. However, regardless of the origin, that massive amount of Hims data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hims Hers news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hims Hers relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hims Hers' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hims Hers alpha.
Hims Hers Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Hims Hers can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Hims Hers Health Historical Investor Sentiment
Investor biases related to Hims Hers' public news can be used to forecast risks associated with an investment in Hims. The trend in average sentiment can be used to explain how an investor holding Hims can time the market purely based on public headlines and social activities around Hims Hers Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Hims Hers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Hims Hers and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Hims Hers news discussions. The higher the estimate score, the more favorable the investor's outlook on Hims Hers.
Hims Hers Maximum Pain Price Across May 16th 2025 Option Contracts
Hims Hers' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Hims Hers close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Hims Hers' options.
Hims Hers Corporate Management
| Brian OShaughnessy | Chief Officer | Profile | |
| Peter MD | Senior Board | Profile | |
| Daniel MD | Senior Health | Profile | |
| Jonathan CFA | VP Relations | Profile | |
| Mike Chi | Chief Officer | Profile | |
| Soleil JD | Chief Secretary | Profile | |
| MD FAAD | VP Board | Profile |
Additional Tools for Hims Stock Analysis
When running Hims Hers' price analysis, check to measure Hims Hers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hims Hers is operating at the current time. Most of Hims Hers' value examination focuses on studying past and present price action to predict the probability of Hims Hers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hims Hers' price. Additionally, you may evaluate how the addition of Hims Hers to your portfolios can decrease your overall portfolio volatility.